Drug Development for Brain Cancer
Drug Development
Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction
Fogal V, Babic I, Chao Y, Pastorino S, Mukthavaram R, Jiang P, Cho YJ, Pingle SC, Crawford JR, Piccioni DE, Kesari S. Oncotarget. 2015 Jan 20;6(2):1157-70.
Drug Development
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
Jiang P, Mukthavaram R, Chao Y, Nomura N, Bharati IS, Fogal V, Pastorino S, Teng D, Cong X, Pingle SC, Kapoor S, Shetty K, Aggrawal A, Vali S, Abbasi T, Chien S, Kesari S. Br J Cancer. 2014 Oct 14;111(8):1562-71.